Actinium Pharmaceuticals
ATNM
#9125
Rank
S$79.37 M
Marketcap
$2.54
Share price
4.66%
Change (1 day)
-61.66%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -S$63.06 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are S$0.08 Million. In 2023 the company made an earning of -S$68.99 Million a decrease over its 2022 earnings that were of -S$45.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$63.06 Million-8.59%
2023 -S$68.99 Million52.24%
2022 -S$45.32 Million36.61%
2021 -S$33.17 Million11.48%
2020 -S$29.76 Million1.46%
2019 -S$29.33 Million-7.37%
2018 -S$31.66 Million-11.46%
2017 -S$35.76 Million10.67%
2016 -S$32.31 Million15.7%
2015 -S$27.93 Million-14.86%
2014 -S$32.8 Million129.19%
2013 -S$14.32 Million-8.55%
2012 -S$15.65 Million
2010 S$0.01 M-152.15%
2009 -S$0.03 Million-39.8%
2008 -S$0.04 Million120.29%
2007 -S$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$49.42 Million-20.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.52 B-938.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.14 Billion 113.75%๐Ÿ‡บ๐Ÿ‡ธ USA